Merit Medical Systems Inc (MMSI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $5.20B
Last updated: Oct 16, 2026 at 1:55 PM ET
Earnings
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Data
Related GNG Research
No research available
Be the first to write about MMSI
Government Contracts
Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.
News
MMSI Valuation and Fair Value
- P/E
- 22.4x
- Forward P/E
- 18.9x
- EV/EBITDA
- 16.0x
- P/FCF
- 26.3x
- PEG
- 1.6x
- P/B
- 3.2x
MMSI Profitability: Margins, ROIC and FCF
- Gross margin
- 49.5%
- Operating margin
- 14.5%
- Net margin
- 9.2%
- ROIC
- 6.5%
- ROE
- 9.2%
- FCF margin
- 12.9%
- FCF yield
- 3.8%
MMSI Competitors
Sector: Healthcare
MMSI Analyst Ratings
- Consensus
- Buy
- Analysts
- 11
- Strong Buy
- 5
- Buy
- 4
- Hold
- 2
- Sell
- 0
- Strong Sell
- 0
MMSI Bull Case vs Bear Case
Bull case
- MMSI beat EPS estimates in 100.0% of its last 8 reported quarters.
- 81.8% of MMSI's analyst ratings are Buy or Strong Buy.
MMSI Earnings: Beat Rate and Next Report
- Beat rate
- 8 of 8 quarters (100.0%)
- Average surprise
- 14.4%
- EPS estimate (fiscal period ending Sep 30, 2026)
- $1.03
- Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
- 6 up, 1 down
Frequently Asked Questions About MMSI
Does MMSI pay dividends?
Merit Medical Systems Inc (MMSI) does not currently pay a regular dividend.
What is MMSI's P/E ratio?
Merit Medical Systems Inc has a price-to-earnings (P/E) ratio of 22.45.
What is MMSI's market cap?
Merit Medical Systems Inc (MMSI) has a market capitalization of $5.20B with a current stock price of $89.57.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.